R. Bjarnason et al., GROWTH-HORMONE TREATMENT PREVENTS THE DECREASE IN INSULIN-LIKE-GROWTH-FACTOR-I GENE-EXPRESSION IN PATIENTS UNDERGOING ABDOMINAL-SURGERY, The Journal of clinical endocrinology and metabolism, 83(5), 1998, pp. 1566-1572
Acquired GH resistance together with reduced skeletal muscle mass are
found in patients with increased protein catabolism due, for example,
to sepsis, trauma, or major surgery. Both administration of glutamine-
containing parenteral nutrition and GH treatment have been found to di
minish this catabolism. The effects of GH are mediated in part by insu
lin-like growth factor I (IGF-I) that is produced in the liver and loc
ally in GH target tissues. The aim of this study was to investigate th
e effect of GH treatment on expression of the IGF-I gene and GH recept
or (GHR) gene in skeletal muscle after major surgery. A new quantitati
ve RT-PCR-based assay was established to measure IGF-I gene expression
. Metabolically healthy patients, without significant preoperative wei
ght loss, who were undergoing elective abdominal surgery were included
in the study. Five patients tone woman and four men) were treated wit
h daily injections of GH (0.3 IU/kg.day) in addition to being given to
tal parenteral nutrition including glutamine (0.28 g/kg.day). The cont
rol group consisted of eight patients (three women and five men), who
were given glutamine-enriched total parenteral nutrition but no GH. A
muscle biopsy was taken from the lateral portion of the quadriceps fem
oris muscle preoperatively (day 0) after induction of anesthesia. A se
cond biopsy was taken under local anesthesia on postoperative day 3. T
otal ribonucleic acid (RNA) was extracted from the muscle biopsies, an
d IGF-I messenger RNA (mRNA) and GHR mRNA were measured by competitive
quantitative RT-PCR assays. IGF-I mRNA and GHR mRNA levels were relat
ed to the expression of a housekeeping gene (cyclophilin). In the cont
rol group, IGF-I mRNA levels decreased from 1505 +/- 265 (mean +/- SEM
) transcripts/cpm cyclophilin on day 0 to 828 +/- 172 on day 3 (P < 0.
05). In contrast, IGF-I mRNA levels did not change in the GH-treated g
roup (1188 +/- 400 transcripts/cpm cyclophilin on day 0 vs. 1089 +/- 3
42 transcripts/cpm cyclophilin on day 3). No statistically significant
changes were seen in GHR expression. We conclude that administration
of GH prevents the reduction in IGF-I gene expression in skeletal musc
le after abdominal surgery.